BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24696091)

  • 41. In vivo pharmaco-proteomic analysis of hydroxyurea induced changes in the sickle red blood cell membrane proteome.
    Ghatpande SS; Choudhary PK; Quinn CT; Goodman SR
    J Proteomics; 2010 Jan; 73(3):619-26. PubMed ID: 19914412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.
    Kaku H; Cheng KF; Al-Abed Y; Rothstein TL
    J Immunol; 2014 Dec; 193(12):5904-13. PubMed ID: 25392527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19.
    Elsaghir A; El-Sabaa EMW; Zahran AM; Mandour SA; Salama EH; Aboulfotuh S; El-Morshedy RM; Tocci S; Mandour AM; Ali WE; Abdel-Wahid L; Sayed IM; El-Mokhtar MA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of hyperoxic and hyperbaric conditions on the adenosinergic pathway and CD26 expression in rat.
    Bruzzese L; Rostain JC; Née L; Condo J; Mottola G; Adjriou N; Mercier L; Berge-Lefranc JL; Fromonot J; Kipson N; Lucciano M; Durand-Gorde JM; Jammes Y; Guieu R; Ruf J; Fenouillet E
    J Appl Physiol (1985); 2015 Jul; 119(2):140-7. PubMed ID: 25997945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ankylosing spondylitis monocyte-derived macrophages express increased level of A
    Akhtari M; Zargar SJ; Mahmoudi M; Vojdanian M; Rezaeimanesh A; Jamshidi A
    Clin Rheumatol; 2018 Jun; 37(6):1589-1595. PubMed ID: 29524036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The potential role of adenosine signaling in the pathogenesis of melanoma.
    Bahreyni A; Rezaei M; Khazaei M; Fuiji H; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    Biochem Pharmacol; 2018 Oct; 156():451-457. PubMed ID: 30232037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxic and genotoxic monitoring of sickle cell anaemia patients treated with hydroxyurea.
    Khayat AS; Antunes LM; Guimarães AC; Bahia MO; Lemos JA; Cabral IR; Lima PD; Amorim MI; Cardoso PC; Smith MA; Santos RA; Burbano RR
    Clin Exp Med; 2006 Mar; 6(1):33-7. PubMed ID: 16550342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.
    Lanzkron S; Haywood C; Segal JB; Dover GJ
    Am J Hematol; 2006 Dec; 81(12):927-32. PubMed ID: 16924648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sickle cell anemia induces changes in peripheral lymphocytes E-NTPDase/E-ADA activities and cytokines secretion in patients under treatment.
    Castilhos LG; Doleski PH; Bertoldo TM; Passos DF; Bertoncheli Cde M; Rezer JF; Schlemmer JB; Leal DB
    Biomed Pharmacother; 2015 Jul; 73():102-8. PubMed ID: 26211589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of curcumin on the activities of the enzymes that hydrolyse adenine nucleotides in platelets from cigarette smoke-exposed rats.
    dos Santos Jaques JA; Ruchel JB; Schlemmer KB; Pimentel VC; Bagatini M; Souza Vdo C; Moretto MB; Morsch VM; Schetinger MR; Leal DB
    Cell Biochem Funct; 2011 Dec; 29(8):630-5. PubMed ID: 22139626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
    Flanagan JM; Steward S; Howard TA; Mortier NA; Kimble AC; Aygun B; Hankins JS; Neale GA; Ware RE
    Br J Haematol; 2012 Apr; 157(2):240-8. PubMed ID: 22360576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of adenosine receptor engagement by ecto-adenosine deaminase.
    Hashikawa T; Hooker SW; Maj JG; Knott-Craig CJ; Takedachi M; Murakami S; Thompson LF
    FASEB J; 2004 Jan; 18(1):131-3. PubMed ID: 14630704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study.
    Lima CF; Tamegnon A; Rodriguez S; Maru D; Martin PL; Cooper ZA; Rodriguez-Canales J; Parra ER
    Pathobiology; 2024; 91(3):205-218. PubMed ID: 37926083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroxyurea (hydroxycarbamide) genotoxicity in pediatric patients with sickle cell disease.
    Rodriguez A; Duez P; Dedeken L; Cotton F; Ferster A
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27022. PubMed ID: 29512872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea.
    Friedrisch JR; Prá D; Maluf SW; Bittar CM; Mergener M; Pollo T; Kayser M; da Silva MA; Henriques JA; da Rocha Silla LM
    Mutat Res; 2008 Jan; 649(1-2):213-20. PubMed ID: 17988936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia.
    Bagdasaryan R; Glasser L; Quillen K; Chaves F; Xu D
    Lab Hematol; 2007; 13(3):93-7. PubMed ID: 17984040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of low CD73 expression on synovial lymphocytes with reduced adenosine generation and higher disease severity in juvenile idiopathic arthritis.
    Botta Gordon-Smith S; Ursu S; Eaton S; Moncrieffe H; Wedderburn LR
    Arthritis Rheumatol; 2015 Feb; 67(2):545-54. PubMed ID: 25418634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization.
    Alam MS; Costales MG; Cavanaugh C; Williams K
    Biomolecules; 2015 May; 5(2):775-92. PubMed ID: 25950510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.
    Gambero S; Canalli AA; Traina F; Albuquerque DM; Saad ST; Costa FF; Conran N
    Eur J Haematol; 2007 Feb; 78(2):144-51. PubMed ID: 17313560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia.
    Brunetta DM; De Santis GC; Silva-Pinto AC; Oliveira de Oliveira LC; Covas DT
    Acta Haematol; 2015; 133(3):287-94. PubMed ID: 25472687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.